Earnings
PFE
43.83
-0.25%
-0.11
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
1.78B
10.44B
--
7.93B
--
--
0.00
--
8.05B
--
--
6.87B
35.07B
15.29B
--
20.26B
--
49.58B
28.47B
--
5.56B
119.16B
154.23B
--
4.31B
701.00M
--
--
--
--
--
3.38B
--
--
--
15.53B
25.92B
37.13B
--
--
4.06B
23.64B
65.07B
90.76B
470.00M
88.67B
96.77B
-110.99B
--
235.00M
63.24B
63.47B
154.23B
FY 2019-12-31
1.12B
8.53B
--
6.77B
--
--
0.00
--
7.07B
--
--
9.32B
32.80B
14.26B
--
20.15B
--
48.20B
33.94B
--
18.25B
134.79B
167.59B
--
3.89B
14.73B
--
--
--
--
--
2.66B
--
--
--
14.56B
37.30B
35.95B
--
--
5.65B
25.24B
67.15B
104.15B
468.00M
87.43B
97.67B
-110.80B
--
303.00M
63.14B
63.45B
167.59B
FY 2018-12-31
1.14B
17.69B
--
8.03B
--
--
0.00
--
7.51B
--
--
15.56B
49.93B
13.38B
--
2.77B
--
53.41B
35.21B
--
4.72B
109.50B
159.42B
--
4.67B
4.05B
--
--
--
--
--
2.40B
--
--
--
15.96B
31.86B
32.91B
--
--
3.70B
27.20B
64.16B
95.66B
467.00M
86.25B
89.55B
-101.61B
--
351.00M
63.41B
63.76B
159.42B
FY 2017-12-31
1.34B
18.65B
--
8.22B
--
--
0.00
--
7.58B
--
--
5.35B
41.14B
13.87B
--
7.01B
--
55.95B
48.74B
--
5.08B
130.66B
171.80B
--
4.66B
6.41B
--
--
--
--
--
2.20B
--
--
--
13.62B
30.43B
33.54B
--
--
3.90B
32.28B
70.06B
100.14B
464.00M
84.28B
85.29B
-89.42B
--
348.00M
71.31B
71.66B
171.80B
FY 2016-12-31
2.60B
15.26B
--
8.22B
--
--
0.00
--
6.78B
--
--
6.09B
38.95B
13.32B
--
7.12B
--
54.45B
52.65B
--
5.13B
132.67B
171.62B
--
4.54B
6.46B
--
--
--
--
--
2.49B
--
--
--
13.40B
31.11B
31.40B
--
--
30.75B
18.51B
80.96B
111.78B
461.00M
82.69B
71.77B
-84.36B
--
296.00M
59.54B
59.84B
171.62B

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out PFE latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Pfizer recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.